The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2
Viruses · 2023
DOI: 10.3390/v15040989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Josefina Vicente und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Virología, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires 1428…. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANPCYT, CONICET.
Abstract (Originalsprache)
New antiviral treatments are needed to deal with the unpredictable emergence of viruses. Furthermore, vaccines and antivirals are only available for just a few viral infections, and antiviral drug resistance is an increasing concern. Cyanidin (a natural product also called A18), a key flavonoid that is present in red berries and other fruits, attenuates the development of several diseases, through its anti-inflammatory effects. Regarding its mechanism of action, A18 was identified as an IL-17A inhibitor, resulting in the attenuation of IL-17A signaling and associated diseases in mice. Importantly, A18 also inhibits the NF-κB signaling pathway in different cell types and conditions in vitro and in vivo. In this study, we report that A18 restricts RSV, HSV-1, canine coronavirus, and SARS-CoV-2 multiplication, indicating a broad-spectrum antiviral activity. We also found that A18 can control cytokine and NF-κB induction in RSV-infected cells independently of its antiviral activity. Furthermore, in mice infected with RSV, A18 not only significantly reduces viral titers in the lungs, but also diminishes lung injury. Thus, these results provide evidence that A18 could be used as a broad-spectrum antiviral and may contribute to the development of novel therapeutic targets to control these viral infections and pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Virología, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires 1428, Argentina.
- Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), CONICET-Universidad de Buenos Aires, Buenos Aires 1428, Argentina.
- Unidad Operativa Centro de Contención Biológica (UOCCB), Administración Nacional de Laboratorios e Institutos de Salud (ANLIS), Buenos Aires 1282, Argentina.
- Instituto de Medicina Traslacional, Trasplante y Bioingeniería (IMETTYB)-CONICET, Buenos Aires 1093, Argentina.
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires 1425, Argentina.
- Laboratorio de Virología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires 1417, Argentina.
ORCID-Profile: Paula Martelliti, Mariana Viegas, Andrea Alejandra Barquero, Carlos Alberto Bueno
Förderung
- ANPCYT
- CONICET
Zitieren
APA
Vicente, J., Benedetti, M., Martelliti, P., Vázquez, L., Gentilini, M. V., Peñaranda Figueredo, F. A., Nabaes Jodar, M. S., Viegas, M., Barquero, A. A., & Bueno, C. A. (2023). The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2. Viruses. https://doi.org/10.3390/v15040989
Vancouver
Vicente J, Benedetti M, Martelliti P, Vázquez L, Gentilini MV, Peñaranda Figueredo FA, et al. The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2. Viruses. 2023. doi:10.3390/v15040989
BibTeX
@article{Vicente2023,
author = {Vicente, Josefina and Benedetti, Martina and Martelliti, Paula and Vázquez, Luciana and Gentilini, María Virginia and Peñaranda Figueredo, Freddy Armando and Nabaes Jodar, Mercedes Soledad and Viegas, Mariana and Barquero, Andrea Alejandra and Bueno, Carlos Alberto},
title = {The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15040989}
}
EUVIMED